Scientists Reverse Anxiety by Targeting Tiny Brain Circuit in Breakthrough Study
Researchers identified specific amygdala neurons whose imbalanced activity alone can trigger pathological behaviors, then successfully restored normal function.
Scientists have achieved a remarkable breakthrough in understanding and treating anxiety by identifying a specific brain circuit that plays a central role in anxiety, depression-like behaviors, and social withdrawal. Even more striking, researchers found that simply restoring balance within this tiny neural network was sufficient to reverse several of these behaviors in laboratory mice.
The research, led by Juan Lerma at the Institute for Neurosciences, focused on the amygdala, a brain region long known to regulate emotions such as fear and anxiety. However, the team discovered that a particular group of neurons within this area can have a disproportionately powerful influence on emotional and social behavior. "We already knew the amygdala was involved in anxiety and fear, but now we've identified a specific population of neurons whose imbalanced activity alone is sufficient to trigger pathological behaviors," Lerma explained.
The scientists used genetically engineered mice that produced unusually high levels of the Grik4 gene, which increased the number of GluK4 glutamate receptors and made certain neurons more excitable than normal. These animals displayed behaviors resembling anxiety and social withdrawal, traits often associated with conditions such as autism and schizophrenia. The mouse model had been developed by the same laboratory in 2015 specifically to study these behavioral patterns.
The breakthrough came when researchers targeted neurons in the basolateral amygdala and normalized Grik4 gene activity in this region. This simple intervention restored proper communication with inhibitory neurons in the centrolateral amygdala called regular firing neurons. "That simple adjustment was enough to reverse anxiety-related and social deficit behaviors, which is remarkable," said first author Álvaro García.
Crucially, the researchers validated their findings by applying the same intervention to wild-type mice that naturally displayed elevated anxiety levels. The treatment reduced anxiety in those animals as well, suggesting the mechanism extends beyond a specific genetic model. "This validates our findings and gives us confidence that the mechanism we identified is not exclusive to a specific genetic model, but may represent a general pathway for anxiety disorders," the researchers noted. The study, published in iScience, represents a significant step toward developing targeted treatments for anxiety and related conditions.
